BioSpace News Archive

Biotech Bay

Alterity Therapeutics Issues Shareholder Letter Highlighting Pipeline Advances and Key Upcoming Milestones

Alterity Therapeutics, a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, issued a letter to shareholders.

January 22, 2024
·
7 min read
Business

SIGA Announces Appointment of Diem Nguyen, Ph.D., MBA, as New Chief Executive Officer

SIGA Technologies, Inc. today announced that Diem Nguyen, Ph.D., will join the Company as chief executive officer (CEO), effective January 27, 2024, and will also be appointed to the Company’s Board of Directors.

January 22, 2024
·
8 min read
Lone Star Bio

Marker Therapeutics Receives Approval from United States Adopted Name (USAN) Council and International Nonproprietary Names (INN) Expert Committee for “Neldaleucel” as Nonproprietary Name for MT-601

Marker Therapeutics, Inc. announced today that the United States Adopted Names (USAN) Council, and the World Health Organization (WHO) International Nonproprietary Names (INN) expert committee has approved “ neldaleucel ” as the nonproprietary (generic) name for MT-601, a multi-tumor associated antigen (multiTAA)-specific T cell product candidate for the treatment of patients with lymphoma.

January 22, 2024
·
5 min read
Pharm Country

Amarin Chairman & CEO Issue Letter to Shareholders - Jan 22, 2024

Amarin Corporation plc announced that the Company’s Chairman of the Board, Odysseas Kostas, M.D., and President & CEO, Patrick Holt, issued the following letter to Amarin shareholders.

January 22, 2024
·
5 min read
BioMidwest

Surmodics Announces Successful Early Clinical Use of Pounce™ LP (Low Profile) Thrombectomy System, Designed to Address a Critical, Unmet Need by Facilitating Removal of Thrombi and Emboli Below the Knee

Surmodics, Inc. today announced successful early clinical use of the company’s Pounce™ LP (Low Profile) Thrombectomy System.

January 22, 2024
·
6 min read
Policy

CORBEVAX®, a COVID19 Vaccine Developed by Bio E-India Based on the RBD Protein Antigen Technology From Texas Children’s Hospital Center for Vaccine Development, Receives World Health Organization Emergency Use Listing Approval

Texas Children’s Hospital announces that Biological E’s CORBEVAX®, a traditional, recombinant protein-based COVID-19 vaccine has received World Health Organization approval under Emergency Use Listing.

January 22, 2024
·
7 min read
Location Change, Speaker Update for the 2024 Wilson Sonsini Entrepreneur and Investor Life Sciences Summit

BioUtah, Utah’s trade association dedicated to the life sciences community, in partnership with the University of Utah’s Technology Licensing Office, today announced a venue change and speaker update for the 2024 Entrepreneur and Investor Life Sciences (E&I Summit) sponsored by Wilson Sonsini.

January 22, 2024
·
2 min read
Brenus Pharma, Winner of the Call for Proposals “Innovations in Biotherapies and Bioproduction for France 2030", Receives €5 Million for Its Anticancer Vaccine Immunotherapy

Brenus Pharma announces the financing of nearly 5 million euros for its STC-1010 project as the winner of the “Innovations in Biotherapy and Bioproduction” call for proposals from France 2030.

January 22, 2024
·
2 min read
BioMidwest

ASTCT, AACI, and ACCC Launch RECUR Initiative to Enhance Patient Access to CAR T Therapy

The American Society for Transplantation and Cellular Therapy (ASTCT), the Association of American Cancer Institutes (AACI), and the Association of Community Cancer Centers (ACCC) recently announced the RECUR initiative.

January 22, 2024
·
4 min read
Business

Bayer appoints Nelson Ambrogio as new Head of Radiology Business at Pharmaceuticals Division

Bayer announced Nelson Ambrogio as the new Head of the Radiology Business at its Pharmaceuticals Division, effective April 1, 2024.

January 22, 2024
·
4 min read